China Pharma Holdings Stock Price on September 18, 2024
| CPHI Stock | USD 0.20 0.01 5.26% |
Below is the normalized historical share price chart for China Pharma Holdings extending back to April 17, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of China Pharma stands at 0.20, as last reported on the 22nd of November, with the highest price reaching 0.20 and the lowest price hitting 0.19 during the day.
If you're considering investing in China Stock, it is important to understand the factors that can impact its price. China Pharma is out of control at the moment. China Pharma Holdings secures Sharpe Ratio (or Efficiency) of 0.0223, which signifies that the company had a 0.0223% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for China Pharma Holdings, which you can use to evaluate the volatility of the firm. Please confirm China Pharma's Downside Deviation of 7.67, mean deviation of 4.27, and Risk Adjusted Performance of 0.0176 to double-check if the risk estimate we provide is consistent with the expected return of 0.16%.
The China Pharma's current Common Stock Shares Outstanding is estimated to increase to about 3.8 M, while Total Stockholder Equity is projected to decrease to under 7.1 M. . As of now, China Pharma's Price Fair Value is increasing as compared to previous years. China Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of April 2002 | 200 Day MA 0.2838 | 50 Day MA 0.2314 | Beta 0.711 |
China |
Sharpe Ratio = 0.0223
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CPHI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.04 actual daily | 62 62% of assets are less volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average China Pharma is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Pharma by adding it to a well-diversified portfolio.
Price Book 0.6603 | Enterprise Value Ebitda (225.89) | Price Sales 0.5914 | Shares Float 7.9 M | Wall Street Target Price 3 |
China Pharma Valuation on September 18, 2024
It is possible to determine the worth of China Pharma on a given historical date. On September 18, 2024 China was worth 0.21 at the beginning of the trading date compared to the closed value of 0.23. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of China Pharma stock. Still, in general, we apply an absolute valuation method to find China Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of China Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against China Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 0.20 | 0.23 | 0.20 | 0.23 | 296,234 | |
09/18/2024 | 0.21 | 0.23 | 0.21 | 0.23 | 230,776 |
| 0.23 | 0.23 | 0.21 | 0.22 | 174,987 |
| Backtest China Pharma | | | China Pharma History | | | China Pharma Valuation | Previous | Next |
China Pharma Trading Date Momentum on September 18, 2024
| On September 19 2024 China Pharma Holdings was traded for 0.22 at the closing time. The top price for the day was 0.23 and the lowest listed price was 0.21 . The trading volume for the day was 175 K. The trading history from September 19, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.35% . The overall trading delta against the current closing price is 8.70% . |
China Pharma Holdings Fundamentals Correlations and Trends
By evaluating China Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among China Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. China financial account trend analysis is a perfect complement when working with valuation or volatility modules.About China Pharma Stock history
China Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for China is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in China Pharma Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing China Pharma stock prices may prove useful in developing a viable investing in China Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.4 M | 3.8 M | |
| Net Loss | -3.1 M | -3.2 M |
China Pharma Stock Technical Analysis
China Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
China Pharma Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
China Pharma Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
China Pharma November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how China Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading China Pharma shares will generate the highest return on investment. By undertsting and applying China Pharma stock market strength indicators, traders can identify China Pharma Holdings entry and exit signals to maximize returns
China Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for China Pharma's price direction in advance. Along with the technical and fundamental analysis of China Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of China to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0176 | |||
| Jensen Alpha | 0.1755 | |||
| Total Risk Alpha | (0.72) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for China Stock analysis
When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |